1. Regulus Therapeutics to participate in Leerink Partners Healthcare Conference. 2. Management team fireside chat scheduled for March 11, 2025. 3. Live event and replays to be available on the company’s website.
Management visibility and engagement can positively influence investor sentiment. Historical events show that similar engagements often lead to increased stock interest.
Involvement in significant industry events increases exposure and potential for investor interest. However, no direct product launches or financial announcements are present to drastically influence stock price.
Increased visibility and engagement during the conference may result in immediate investor reactions. Similar past events suggest potential near-term stock volatility.
/PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced that members of the management team will participate in a fireside chat at the Leerink Partners 2025 Global Healthcare Conference on Tuesday, March 11th at 3:40 p.m. ET.
The live event and replay of the presentation will be available under "Events and Presentations" through the investor relations section of the Company's website at https://ir.regulusrx.com/events and archived for 90 days following the presentation date.
Regulus Therapeutics Inc. (Nasdaq: RGLS) is a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs. Regulus has leveraged its oligonucleotide drug discovery and development expertise to develop a pipeline complemented by a rich intellectual property estate in the microRNA field. Regulus maintains its corporate headquarters in San Diego, CA.
SOURCE Regulus Therapeutics Inc.